Morgan Stanley DS ea rep 1/1000 s.../ US61762V8046 /
2024-05-20 10:10:00 PM | Chg. +0.07 | Volume | Bid1:00:05 PM | Ask1:00:05 PM | High | Low |
---|---|---|---|---|---|---|
22.21USD | +0.32% | 21,569 Turnover: 367,671.53 |
19.72Bid Size: 200 | 23.35Ask Size: 700 | 22.27 | 22.09 |
GlobeNewswire
1:15 PM
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
1:10 PM
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
1:07 PM
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
1:05 PM
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
1:00 PM
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
1:00 PM
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
GlobeNewswire
1:00 PM
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
1:00 PM
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
1:00 PM
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
1:00 PM
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
1:00 PM
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
1:00 PM
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
1:00 PM
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...